Context-dependent regulation of lipid homeostasis by miR-122: Molecular mechanisms, disease relevance, and therapeutic implications
Biochemical Pharmacology · 2027-01 · 255 · 118659
DOI: 10.1016/j.bcp.2026.118659 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2027-01. Verfasst von Mengpu Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China; Department of Nutrition, Key Laboratory…. Die Arbeit nennt 134 Literaturangaben.
Abstract (Originalsprache)
miR-122 is a liver-enriched microRNA that shapes systemic lipid homeostasis by coordinating hepatic de novo lipogenesis, oxidative disposal, intracellular storage, and lipoprotein export. Mechanistically, miR-122 intersects with energy-sensing pathways centered on AMPK, modulates lipogenesis through Sirtuin-LKB1/AMPK control, influences triglyceride handling via YY1-linked transcriptional programs, and engages noncoding RNA circuits that regulate autophagy. Furthermore, intracellular miR-122 regulates lipid peroxidation (ferroptosis) in a highly context-dependent manner: it buffers against oxidative injury in steatotic hepatocytes and ischemic tissue injuries, yet actively promotes ferroptosis by targeting SLC7A11 and GPX4 in hepatocellular carcinoma and autoimmune hepatitis. Meanwhile, extracellular vesicle (EV)-associated miR-122 mediates pathogenic inter-organ metabolic communication. Clinically, the progressive decline of hepatic miR-122 drives the transition from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH) and hepatocellular carcinoma (HCC), positioning circulating miR-122 as a highly sensitive diagnostic biomarker. Short-term antagonism via locked nucleic acid (LNA)-based anti-miRs efficiently lowers circulating cholesterol, yet preclinical models suggest that prolonged suppression risks progressive hepatic inflammatory remodeling and steatofibrosis. Conversely, for advanced liver diseases characterized by miR-122 depletion, miR-122 replacement therapies show potential to restore metabolic resilience and suppress fibrogenesis. This review synthesizes current mechanistic evidence and highlights the development of miR-122-targeted nucleic acid drugs and the therapeutic exploitation of exosomal vectors, providing a translational scene for managing lipid-driven metabolic and hepatic disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China; Department of Nutrition, Key Laboratory of Biological Defense, Ministry of Education, Second Military Medical…
- Department of Nutrition, Key Laboratory of Biological Defense, Ministry of Education, Second Military Medical University (Naval Medical University), Shanghai, China.
- Department of Pharmaceutical Analysis, Shanghai Key Laboratory for Pharmaceutical Metabolite Research, Second Military Medical University (Naval Medical University), Shanghai, China; National Key Laboratory of Medical I…
Zitieren
APA
Wu, M., Du, Q., Wang, D., Shen, H., & Tang, Y. (2027). Context-dependent regulation of lipid homeostasis by miR-122: Molecular mechanisms, disease relevance, and therapeutic implications. Biochemical Pharmacology, 255, 118659. https://doi.org/10.1016/j.bcp.2026.118659
Vancouver
Wu M, Du Q, Wang D, Shen H, Tang Y. Context-dependent regulation of lipid homeostasis by miR-122: Molecular mechanisms, disease relevance, and therapeutic implications. Biochemical Pharmacology. 2027;255:118659. doi:10.1016/j.bcp.2026.118659
BibTeX
@article{Wu2027,
author = {Wu, Mengpu and Du, Qiqi and Wang, Dongyao and Shen, Hui and Tang, Yuxiao},
title = {Context-dependent regulation of lipid homeostasis by miR-122: Molecular mechanisms, disease relevance, and therapeutic implications},
journal = {Biochemical Pharmacology},
year = {2027},
volume = {255},
pages = {118659},
doi = {10.1016/j.bcp.2026.118659}
}
EUVIMED